SEARCH

SEARCH BY CITATION

References

  • 1
    Chiquete E, Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico: a systematic review. Intervirology 2007; 50: 18.
  • 2
    Abdel-Hamid M, El-Daly M, El-Kafrawy S, et al. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol 2002; 40: 16569.
  • 3
    Kershenobich D, Razavi HA, Cooper CL, et al. Applying a system approach to forecast the total HCV-infected population size-Model validation using US data. Liver Int 2011; 31(Suppl. 2): 419.
  • 4
    Law MG. Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group. J Gastroenterol Hepatol 1999; 14: 11007.
  • 5
    Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 2003; 26: 17184.
  • 6
    Dore GJ, MacDonald M, Law MG, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. Aust Fam Physician 2003; 32: 7968.
  • 7
    Robotin MC, Copland J, Tallis G, et al. Surveillance for newly acquired hepatitis C in Australia. J Gastroenterol Hepatol 2004; 19: 2838.
  • 8
    Department of Health and Ageing. National Hepatitis C Testing Policy. Hepatitis C subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, Australia, 2007.
  • 9
    Razali K, Thein HH, Bell J, et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 2007; 91: 22835.
  • 10
    Razali K, Amin J, Dore GJ, Law MG, HCV Projections Working Group. Modelling and calibration of the hepatitis C epidemic in Australia. Stat Methods Med Res 2009; 18: 25370.
  • 11
    Amin J, Gidding H, Gilbert G, et al. Hepatitis C prevalence-a nationwide serosurvey. Commun Dis Intell 2004; 28: 51721.
  • 12
    Law MG, Dore GJ, Bath N, et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003; 32: 71724.
  • 13
    Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 116.
  • 14
    Balogun MA, Ramsay ME, Hesketh LM, et al. The prevalence of hepatitis C in England and Wales. J Infect 2002; 45: 21926.
  • 15
    Alter MJ. Hepatitis C virus infection in the United States. J Hepatol 1999; 31 (Suppl. 1): 8891.
  • 16
    Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. J Infect 2009; 58: 37582.
  • 17
    Falster K, Kaldor JM, Maher L. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995–2004. J Urban Health 2009; 86: 10618.
  • 18
    Bowden FJ, O'Keefe EJ, Primrose R, Currie MJ. Sexually transmitted infections, blood-borne viruses and risk behaviour in an Australian senior high school population-the SHLiRP study. Sex Health 2005; 2: 22936.
  • 19
    McDonald A. HIV infection, AIDS, hepatitis C, and sexually transmissible infections in Australia: national surveillance results to December 1998. N S W Public Health Bull 2000; 11: 5860.
  • 20
    Sfameni SF, Francis B, Wein P. Seroprevalence and assessment of risk factors for hepatitis C virus infection in pregnancy. Aust N Z J Obstet Gynaecol 2000; 40: 2637.
  • 21
    Mison LM, Young IF, O'Donoghue M, et al. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population. Transfusion 1997; 37: 738.
  • 22
    Archer GT, Buring ML, Clark B, et al. Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust 1992; 157: 2257.
  • 23
    Allain JP, Coghlan PJ, Kenrick KG, et al. Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNA. Blood 1991; 78: 24628.
  • 24
    National notifiable diseases surveillance system. Austrialian Government, Department of Health and Aging, 2009. Available at http://www9.health.gov.au/cda/source/Rpt_5_sel.cfm (accessed 10 October 2010).
  • 25
    Chen J, McGuinness PH, Koorey DJ, et al. Hepatitis C virus genotypes in a cohort of Australian blood donors and haemophiliac and liver transplant patients. J Gastroenterol Hepatol 1997; 12: 1827.
  • 26
    McCaw R, Moaven L, Locarnini SA, Bowden DS. Hepatitis C virus genotypes in Australia. J Viral Hepat 1997; 4: 3517.
  • 27
    Kaba S, Dutta U, Byth K, et al. Molecular epidemiology of hepatitis C in Australia. J Gastroenterol Hepatol 1998; 13: 91420.
  • 28
    MakI, TseS, HoCF, TseI, WongKH, eds. Surveillance of Viral Hepatitis in Hong Kong – 2008, Update 2008 edn. Hong Kong: Viral Hepatitis Preventive Service, Department of Health, 2009.
  • 29
    Zhao SM, Jiang TL, Li RQ, et al. HCV infection in voluntary donors and its influence on recruitment of donors in Chongqing area. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16: 67680.
  • 30
    Liu F, Chen K, He Z, et al. Hepatitis C seroprevalence and associated risk factors, Anyang, China. Emerg Infect Dis 2009; 15: 181922.
  • 31
    Qiu Y, Shi L, Wang Y, et al. Risk factors for hepatitis C virus infection among blood donors in Beijing and implications for improving the pretesting donor screening process. Transfusion 2008; 48: 120712.
  • 32
    Zhang M, Sun XD, Mark SD, et al. Hepatitis C virus infection, Linxian, China. Emerg Infect Dis 2005; 11: 1721.
  • 33
    Wei D, Zhang Y. Detection of HCV antibody in 1 280 inpatients admitted not for infectious diseases. Di Yi Jun Yi Da Xue Xue Bao 2004; 24: 1125, 1129.
  • 34
    Chen YD, Liu MY, Yu WL, et al. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis Int 2002; 1: 194201.
  • 35
    Qu JB, Zhang ZW, Shimbo S, et al. Urban–rural comparison of HBV and HCV infection prevalence in eastern China. Biomed Environ Sci 2000; 13: 24353.
  • 36
    Zhang ZW, Shimbo S, Qu JB, et al. Hepatitis B and C virus infection among adult women in Jilin Province, China: an urban-rural comparison in prevalence of infection markers. Southeast Asian J Trop Med Public Health 2000; 31: 5306.
  • 37
    Chen M, Xia S. A prevalence study on hepatitis C infection in 4,055 healthy children of Beijing. Zhonghua Yu Fang Yi Xue Za Zhi 1999; 33: 1589.
  • 38
    Huang F, Dong Y, Wang Z. Study on HCV infection and the distribution of HCV genotypes in different populations in Shenyang area. Zhonghua Liu Xing Bing Xue Za Zhi 1998; 19: 1347.
  • 39
    Shimbo S, Zhang ZW, Gao WP, et al. Prevalence of hepatitis B and C infection markers among adult women in urban and rural areas in Shaanxi Province, China. Southeast Asian J Trop Med Public Health 1998; 29: 2638.
  • 40
    Suzuki K, Mizokami M, Cao K, et al. Prevalence of hepatitis C virus infection in Nanjing, southern China. Eur J Epidemiol 1997; 13: 5115.
  • 41
    Fang F, Dong YS, Zhang M. Hepatitis C virus infection in different groups of children in Wuhan area. J Tongji Med Univ 1993; 13: 23943.
  • 42
    Sherlock CH, Zhuo L, Meng XL, Lin XY, Stiver HG. Seroepidemiology of hepatitis C virus in Beijing, China. Clin Diagn Virol 1993; 1: 1722.
  • 43
    Chan GC, Lim W, Yeoh EK. Prevalence of hepatitis C infection in Hong Kong. J Gastroenterol Hepatol 1992; 7: 11720.
  • 44
    Tao QM, Wang Y, Wang H, et al. Preliminary report on seroepidemiology of HCV and HBV infection in northern China. Chin Med J 1992; 105: 20911.
  • 45
    Leung N, Chu C, Tam JS. Viral hepatitis C in Hong Kong. Intervirology 2006; 49: 237.
  • 46
    Ding X, Gu H, Zhong ZH, et al. Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Jpn J Infect Dis 2003; 56: 1922.
  • 47
    Sun Y, Zhao Y, Liu X. Anti-hepatitis C virus screening to prevent hepatitis C virus infection in blood donors. Zhonghua Nei Ke Za Zhi 1995; 34: 6969.
  • 48
    Wu RR, Mizokami M, Lau JY, et al. Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J Med Virol 1995; 45: 1748.
  • 49
    Ito S, Yao DF, Nii C, et al. Incidence of hepatitis C virus (HCV) antibodies and HCV-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 1994; 9: 2459.
  • 50
    Wang Y, Tao QM, Zhao HY, et al. Hepatitis C virus RNA and antibodies among blood donors in Beijing. J Hepatol 1994; 21: 63440.
  • 51
    Tang S. Seroepidemiological study on hepatitis C virus infection among blood donors from various regions in China. Zhonghua Liu Xing Bing Xue Za Zhi 1993; 14: 2714.
  • 52
    Wu X. Investigation on anti-HCV antibody in Shashi District. Zhonghua Liu Xing Bing Xue Za Zhi 1993; 14: 3313.
  • 53
    Zhang YY, Guo LS, Hao LJ, et al. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction. Chin Med J 1993; 106: 1714.
  • 54
    Shan H, Ren FR, Zhao HY, et al. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing. Transfusion 2007; 47: 20116.
  • 55
    Zhou DX, Tang JW, Chu IM, et al. Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong. J Med Virol 2006; 78: 57481.
  • 56
    Lu L, Nakano T, He Y, et al. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 2005; 75: 53849.
  • 57
    Xie Y, Zhao H, Ou WN, et al. The difference in distribution of HCV genotypes between patients infected with HCV by transfusion and non-transfusion routes. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2004; 18: 24750.
  • 58
    Xu B, Lu P, Zhu M. Epidemiological aspects of the genotype of hepatitis C virus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2000; 14: 14850.
  • 59
    El-Zanaty F, Way A. Egypt Demographic and Health Survey, 2008. Cairo, Egypt: Ministry of Health and Population, 2009.
  • 60
    Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 88791.
  • 61
    Medhat A, Shehata M, Magder LS, et al. Hepatitis c in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg 2002; 66: 6338.
  • 62
    Mostafa A, Ebeid E, Mansour T, et al. Seroprevalence of hepatitis B and C in pediatric malignancies. J Egypt Natl Canc Inst 2003; 15: 3342.
  • 63
    Magder LS, Fix AD, Mikhail NN, et al. Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. Int J Epidemiol 2005; 34: 1605.
  • 64
    Plancoulaine S, Mohamed MK, Arafa N, et al. Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut 2008; 57: 126874.
  • 65
    Arafa N, El Hoseiny M, Rekacewicz C, et al. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 2005; 43: 41824.
  • 66
    El Damaty SI, Hassan SK, Mohamed MK, et al. Surveillance system for HCV infection: testing a model based on blood banks. J Egypt Public Health Assoc 2007; 82: 45171.
  • 67
    El-Raziky MS, El-Hawary M, Esmat G, et al. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007; 13: 182832.
  • 68
    Agha S, El-Mashad N, El-Malky M, et al. Prevalence of low positive anti-HCV antibodies in blood donors: schistosoma mansoni co-infection and possible role of autoantibodies. Microbiol Immunol 2006; 50: 44752.
  • 69
    El-Gilany AH, El-Fedawy S. Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt. East Mediterr Health J 2006; 12: 7428.
  • 70
    Tanaka Y, Agha S, Saudy N, et al. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004; 58: 1915.
  • 71
    Arthur RR, Hassan NF, Abdallah MY, et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 1997; 91: 2714.
  • 72
    Bassily S, Hyams KC, Fouad RA, Samaan MD, Hibbs RG. A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse. Am J Trop Med Hyg 1995; 52: 5035.
  • 73
    Darwish NM, Abbas MO, Hady SI, Mohammed TA. Study of the high prevalence of HCV in Egypt. J Egypt Public Health Assoc 1995; 70: 397414.
  • 74
    el Gohary A, Hassan A, Nooman Z, et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 1995; 59: 15561.
  • 75
    McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 88492.
  • 76
    Darwish NM, Abbas MO, Abdelfattah FM, Darwish MA. Hepatitis C virus infection in blood donors in Egypt. J Egypt Public Health Assoc 1992; 67: 22336.
  • 77
    Eassa S, Eissa M, Sharaf SM, Ibrahim MH, Hassanein OM. Prevalence of hepatitis C virus infection and evaluation of a health education program in el-ghar village in zagazig, egypt. J Egypt Public Health Assoc 2007; 82: 379404.
  • 78
    Marzouk D, Sass J, Bakr I, et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut 2007; 56: 110510.
  • 79
    Bakr I, Rekacewicz C, El Hosseiny M, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006; 55: 11837.
  • 80
    Mohamed MK, Bakr I, El-Hoseiny M, et al. HCV-related morbidity in a rural community of Egypt. J Med Virol 2006; 78: 11859.
  • 81
    el-Sadawy M, Ragab H, el-Toukhy H, et al. Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. J Egypt Soc Parasitol 2004; 34: 36784.
  • 82
    Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol 2003; 20: 3817.
  • 83
    Strickland GT, Elhefni H, Salman T, et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002; 67: 43642.
  • 84
    Nafeh MA, Medhat A, Shehata M, et al. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 2000; 63: 23641.
  • 85
    Abdel-Aziz F, Habib M, Mohamed MK, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000; 32: 1115.
  • 86
    Kumar RM, Frossad PM, Hughes PF. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women. Eur J Obstet Gynecol Reprod Biol 1997; 75: 17782.
  • 87
    Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg 1996; 54: 5548.
  • 88
    el-Sayed NM, Gomatos PJ, Rodier GR, et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg 1996; 55: 17984.
  • 89
    el-Nanawy AA, el Azzouni OF, Soliman AT, et al. Prevalence of hepatitis-C antibody seropositivity in healthy Egyptian children and four high risk groups. J Trop Pediatr 1995; 41: 3413.
  • 90
    Quinti I, Renganathan E, El Ghazzawi E, et al. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 1995; 283: 23944.
  • 91
    Abdel-Wahab MF, Zakaria S, Kamel M, et al. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg 1994; 51: 5637.
  • 92
    Kamel MA, Miller FD, el Masry AG, et al. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 1994; 88: 5019.
  • 93
    Farghaly AG, Barakat RM. Prevalence, impact and risk factors of hepatitis C infection. J Egypt Public Health Assoc 1993; 68: 6379.
  • 94
    Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci USA 2010; 107: 1475762.
  • 95
    Saleh DA, Shebl F, Abdel-Hamid M, et al. Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. Trans R Soc Trop Med Hyg 2008; 102: 9218.
  • 96
    Abdel-Hamid M, El-Daly M, Molnegren V, et al. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J Gen Virol 2007; 88: 152631.
  • 97
    Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis 2000; 182: 698707.
  • 98
    El-Zayadi A, Simmonds P, Dabbous H, Selim O. Hepatitis C virus genotypes among HCV-chronic liver disease patients in Egypt: a leading trial. J Egypt Public Health Assoc 1994; 69: 32734.
  • 99
    National AIDS Control Organization (NACO). An action plan for blood safety. National AIDS Control Organisation, Ministry of Health & Family Welfare, Govt. of India, 2003.
  • 100
    Sharma R. South East Asia faces severe shortage of safe blood. BMJ 2000; 320: 1026.
  • 101
    Saravanan S, Velu V, Kumarasamy N, et al. The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India. Int J Infect Dis 2008; 12: 5138.
  • 102
    Hissar SS, Goyal A, Kumar M, et al. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol 2006; 78: 4528.
  • 103
    Thakral B, Marwaha N, Chawla YK, et al. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res 2006; 124: 4318.
  • 104
    Amarapurkar D. Natural history of hepatitis C virus infection. J Gastroenterol Hepatol 2000; 15 (Suppl.): E10510.
  • 105
    Raghuraman S, Shaji RV, Sridharan G, et al. Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India. J Clin Virol 2003; 26: 619.
  • 106
    Chowdhury A, Santra A, Chaudhuri S, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003; 37: 8029.
  • 107
    Sood A, Midha V, Sood N, et al. Chronic hepatitis C in northern India-the pathological and clinical spectrum. J Assoc Physicians India 2004; 52: 3804.
  • 108
    Sood A, Midha V, Awasthi G. Hepatitis C – knowledge & practices among the family physicians. Trop Gastroenterol 2002; 23: 198201.
  • 109
    Kumar A, Sharma KA, Gupta RK, Kar P, Chakravarti A. Prevalence & risk factors for hepatitis C virus among pregnant women. Indian J Med Res 2007; 126: 2115.
  • 110
    Makroo RN, Choudhury N, Jagannathan L, et al. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. Indian J Med Res 2008; 127: 1407.
  • 111
    Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. Jpn J Infect Dis 2007; 60: 38991.
  • 112
    Bagga PK, Singh SP. Seroprevalence of hepatitis C antibodies in healthy blood donors-a prospective study. Indian J Pathol Microbiol 2007; 50: 42932.
  • 113
    Bhattacharya P, Chandra PK, Datta S, et al. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004–2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol 2007; 13: 37303.
  • 114
    Gupta N, Kumar V, Kaur A. Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian J Med Sci 2004; 58: 2557.
  • 115
    Singh B, Kataria SP, Gupta R. Infectious markers in blood donors of East Delhi: prevalence and trends. Indian J Pathol Microbiol 2004; 47: 4779.
  • 116
    Patel Y. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors. Indian J Med Sci 2004; 58: 3067.
  • 117
    Jain A, Rana SS, Chakravarty P, et al. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol 2003; 18: 6957.
  • 118
    Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001; 44: 40912.
  • 119
    Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, south India. Indian J Med Sci 2000; 54: 2703.
  • 120
    Das PK, Harris VK, Sitaram U, et al. Hepatitis C virus prevalence among blood donors from South India. Vox Sang 2000; 78: 2545.
  • 121
    Panigrahi AK, Panda SK, Dixit RK, et al. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol 1997; 51: 16774.
  • 122
    Kumar S, Agnihotri SK. Antibodies to hepatitis C virus in Chandigarh blood donors. Vox Sang 1997; 73: 2589.
  • 123
    Jaiswal SP, Chitnis DS, Naik G, et al. Prevalence of anti-HCV antibodies in central India. Indian J Med Res 1996; 104: 17781.
  • 124
    Arankalle VA, Chadha MS, Jha J, Amrapurkar DN, Banerjee K. Prevalence of anti-HCV antibodies in western India. Indian J Med Res 1995; 101: 913.
  • 125
    Jindal N, Arora U, Singh K. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India. Jpn J Infect Dis 2008; 61: 7981.
  • 126
    Narahari S, Juwle A, Basak S, Saranath D. Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort. Infect Genet Evol 2009; 9: 6435.
  • 127
    Abraham R, Ramakrishna B, Balekuduru A, et al. Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease. Indian J Gastroenterol 2009; 28: 538.
  • 128
    Verma V, Chakravarti A, Kar P. Genotypic characterization of hepatitis C virus and its significance in patients with chronic liver disease from Northern India. Diagn Microbiol Infect Dis 2008; 61: 40814.
  • 129
    Chandra M, Thippavuzzula R, Ramachandra Rao VV, et al. Genotyping of Hepatitis C virus (HCV) in infected patients from South India. Infect Genet Evol 2007; 7: 72430.
  • 130
    Raghuraman S, Abraham P, Sridharan G, et al. HCV genotype 4 – an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 2004; 31: 2538.
  • 131
    Singh S, Malhotra V, Sarin SK. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res 2004; 119: 1458.
  • 132
    Das BR, Kundu B, Khandapkar R, Sahni S. Geographical distribution of hepatitis C virus genotypes in India. Indian J Pathol Microbiol 2002; 45: 3238.
  • 133
    Amarapurkar D, Dhorda M, Kirpalani A, Amarapurkar A, Kankonkar S. Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. J Assoc Physicians India 2001; 49: 9835.
  • 134
    Panigrahi AK, Roca J, Acharya SK, Jameel S, Panda SK. Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol 1996; 48: 1918.
  • 135
    Valliammai T, Thyagarajan SP, Zuckerman AJ, Harrison TJ. Diversity of genotypes of hepatitis C virus in southern India. J Gen Virol 1995; 76 (Part 3): 7116.
  • 136
    Nakamura J, Terajima K, Aoyagi Y, Akazawa K. Cost-effectiveness of the national screening program for hepatitis C virus in the general population and the high-risk groups. Tohoku J Exp Med 2008; 215: 3342.
  • 137
    Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology 2010; 53: 3943.
  • 138
    Moriya T, Koyama T, Tanaka J, Mishiro S, Yoshizawa H. Epidemiology of hepatitis C virus in japan. Intervirology 1999; 42: 1538.
  • 139
    Yoshizawa H, Tanaka J, Miyakawa Y. National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology 2006; 49: 717.
  • 140
    Ohto H, Ishii T, Kitazawa J, et al. Declining hepatitis C virus (HCV) prevalence in pregnant women: impact of anti-HCV screening of donated blood. Transfusion 2010; 693700.
  • 141
    Sata M, Nakano H, Suzuki H, et al. Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan. J Gastroenterol 1998; 33: 21822.
  • 142
    Shimoyama R, Sekiguchi S, Suga M, Sakamoto S, Yachi A. The epidemiology and infection route of asymptomatic HCV carriers detected through blood donations. Gastroenterol Jpn 1993; 28 (Suppl. 5): 15.
  • 143
    Tanaka J, Kumagai J, Katayama K, et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995–2000. Intervirology 2004; 47: 3240.
  • 144
    Fujiyama S, Tanaka M. Hepatitis C: epidemiology and therapy – with special reference to long-term prognosis after IFN therapy. Rinsho Byori 2000; 48: 513.
  • 145
    Nakashima K, Kashiwagi S, Hayashi J, et al. Prevalence of hepatitis C virus infection among female prostitutes in Fukuoka, Japan. J Gastroenterol 1996; 31: 6648.
  • 146
    Yamaguchi K, Kiyokawa H, Machida J, et al. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients. FEMS Microbiol Rev 1994; 14: 2538.
  • 147
    Kihara M, Imai M, Kondoh M, et al. Prevalence of hepatitis C virus and human immunodeficiency virus infection among Japanese female prostitutes. Nippon Koshu Eisei Zasshi 1993; 40: 38791.
  • 148
    Khan M, Husain M, Yano M, et al. Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan. Gastroenterol Jpn 1993; 28 (Suppl. 5): 2831.
  • 149
    Watanabe S, Kano U, Ito T, et al. Prevalence and heterogeneity of serum DNA polymerase activity in patients with non-A, non-B hepatitis and HBsAg-negative blood donors with elevated SGPT. Hepatogastroenterology 1990; 37 (Suppl. 2): 1269.
  • 150
    Matsumoto K, Takahashi M, Tamori A, Nishiguchi S. Present status of community-based HCV screening in Osaka City and evaluation of the utility of follow-up programs on hepatitis]. Nippon Koshu Eisei Zasshi 2008; 55: 7582.
  • 151
    Narai R, Oyama T, Ogawa M, et al. HBV- and HCV- infected workers in the Japanese workplace. J Occup Health 2007; 49: 916.
  • 152
    Taguchi S, Nishioka K, Kawaguchi R, et al. Epidemiological study of hepatitis B and C in 34,336 patients operated at Hiroshima Prefectural Hospital during the period from 1993 to 2000. Masui 2004; 53: 696700.
  • 153
    Nakamura Y, Koh M, Miyoshi E, et al. High prevalence of the hepatitis C virus infection among the inpatients of schizophrenia and psychoactive substance abuse in Japan. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 5917.
  • 154
    Yoshida K, Nakano H, Yoshitomi F, Oshika T. Prevalence of seropositivity for hepatitis C virus in cataract patients and the general population. J Cataract Refract Surg 2002; 28: 178992.
  • 155
    Wada I, Hara T, Kajihara S, et al. Population-based study of hepatitis C virus infection and hepatocellular carcinoma in western Japan. Hepatol Res 2002; 23: 1824.
  • 156
    Okayama A, Stuver SO, Tabor E, et al. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat 2002; 9: 4351.
  • 157
    Ishi K, Suzuku F, Saito A, Yoshimoto S, Kubota T. Prevalence of human immunodeficiency virus, hepatitis B and hepatitis C virus antibodies and hepatitis B antigen among commercial sex workers in Japan. Infect Dis Obstet Gynecol 2001; 9: 2159.
  • 158
    Inoue Y, Sulaiman HA, Matsubayashi K, et al. Genotypic analysis of hepatitis C virus in blood donors in Indonesia. Am J Trop Med Hyg 2000; 62: 928.
  • 159
    Yoshii E, Shinzawa H, Saito T, et al. Molecular epidemiology of hepatitis C virus infection in an area endemic for community-acquired acute hepatitis C. Tohoku J Exp Med 1999; 188: 3116.
  • 160
    Kuboki M, Shinzawa H, Shao L, et al. A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: age and sex-related seroprevalence of anti-HCV antibody, frequency of viremia, biochemical abnormality and histological changes. Liver 1999; 19: 8896.
  • 161
    Kayaba K, Igarashi M, Okamoto H, Tsuda F. Prevalence of anti-hepatitis C antibodies in a rural community without high mortality from liver disease in Niigata prefecture. J Epidemiol 1998; 8: 2505.
  • 162
    Miyajima I, Sata M, Murashima S, et al. Prevalence of hepatitis C antibodies in health care personnel. Kansenshogaku Zasshi 1997; 71: 1037.
  • 163
    Fukuizumi K, Sata M, Suzuki H, Nakano H, Tanikawa K. Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study. Scand J Infect Dis 1997; 29: 3457.
  • 164
    Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. Scand J Infect Dis 1997; 29: 238.
  • 165
    Watanabe Y, Machida K, Sato A, Ota S, Kiyosawa K. Survey for hepatitis in an isolated endemic area. Nippon Koshu Eisei Zasshi 1996; 43: 98996.
  • 166
    Yamakawa Y, Sata M, Suzuki H, Noguchi S, Tanikawa K. Higher elimination rate of hepatitis C virus among women. J Viral Hepat 1996; 3: 31721.
  • 167
    Ishibashi M, Shinzawa H, Kuboki M, Tsuchida H, Takahashi T. Prevalence of inhabitants with anti-hepatitis C virus antibody in an area following an acute hepatitis C epidemic: age-and area-related features. J Epidemiol 1996; 6: 17.
  • 168
    Ichimura H, Kurimura O, Tamura I, et al. Prevalence of blood-borne viruses among intravenous drug users and alcoholics in Hiroshima, Japan. Int J STD AIDS 1995; 6: 4413.
  • 169
    Yanaga K, Wakiyama S, Soejima Y, et al. Hepatitis C virus infection among Japanese general surgical patients. World J Surg 1995; 19: 6946.
  • 170
    Hayashi J, Kishihara Y, Yamaji K, et al. Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995; 90: 7949.
  • 171
    Tawaraya H, Ohkoshi S, Kuwana K, et al. Epidemiologic survey and genetic analysis of endemic hepatitis C virus infection in a Japanese town with a high prevalence of hepatitis B virus carriers. J Med Virol 1995; 45: 36772.
  • 172
    Fukui M. Natural history of HCV seropositive cases found in health screening. Hokkaido Igaku Zasshi 1995; 70: 6982.
  • 173
    Kiyosawa K, Tanaka E, Sodeyama T, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology 1994; 106: 1596602.
  • 174
    Hayashi J, Yoshimura E, Nabeshima A, et al. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan. J Gastroenterol 1994; 29: 27681.
  • 175
    Sato Y, Matsunami M, Maruoka H, et al. A seroepidemiological study of hepatitis C virus (HCV) in an area with a high prevalence of chronic liver disease in the Kyushu district of Japan. Kurume Med J 1994; 41: 4150.
  • 176
    Goto T, Misumi J, Shimaoka A, et al. Seroepidemiological study on hepatitis C virus infection in an endemic area of hepatitis C virus. Kansenshogaku Zasshi 1993; 67: 63541.
  • 177
    Nakashima K, Kashiwagi S, Hayashi J, et al. Low prevalence of hepatitis C virus infection among hospital staff and acupuncturists in Kyushu, Japan. J Infect 1993; 26: 1725.
  • 178
    Nakashima K, Kashiwagi S, Hayashi J, et al. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol 1992; 136: 11327.
  • 179
    Suou T, Ikuta Y, Hasegawa M, Kawasaki H. Prevalence of HCV antibodies in Yatsuka town of Simane prefecture, Japan. Nippon Shokakibyo Gakkai Zasshi 1992; 89: 11738.
  • 180
    Fujiyama S, Kawano S, Sato S, et al. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Hepatogastroenterology 1992; 39: 1615.
  • 181
    Tanaka E, Kiyosawa K, Sodeyama T, et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors. Am J Trop Med Hyg 1992; 46: 4604.
  • 182
    Ochi S, Onji M, Shiraishi K, et al. Prevalence of hepatitis C virus antibody in an area endemic for hepatitis B virus and human T cell leukaemia virus. J Gastroenterol Hepatol 1991; 6: 599602.
  • 183
    Michitaka K, Horiike N, Ohta Y. An epidemiological study of hepatitis C virus infection in a local district in Japan. Rinsho Byori 1991; 39: 58691.
  • 184
    Ito S, Ito M, Cho MJ, Shimotohno K, Tajima K. Massive sero-epidemiological survey of hepatitis C virus: clustering of carriers on the southwest coast of Tsushima, Japan. Jpn J Cancer Res 1991; 82: 13.
  • 185
    Tanaka J, Mizui M, Nagakami H, et al. Incidence rates of hepatitis B and C virus infections among blood donors in Hiroshima, Japan, during 10 years from 1994 to 2004. Intervirology 2008; 51: 3341.
  • 186
    Katayama K, Tanaka J, Yoshizawa H. Past trends in hepatitis C virus infection and route of transmission in Japan. Rinsho Byori 2001; 49: 7416.
  • 187
    Ohno O, Mizokami M, Wu RR, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35: 2017.
  • 188
    Ohno T, Mizokami M, Yamauchi M, et al. Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus. J Gastroenterol 1995; 30: 20914.
  • 189
    Kobayashi M, Kumada H, Chayama K, et al. Prevalence of HCV genotype among patients with chronic liver diseases in the Tokyo metropolitan area. J Gastroenterol 1994; 29: 5837.
  • 190
    Shin HR, Hwang SY, Nam CM. The prevalence of hepatitis C virus infection in Korea: pooled analysis. J Korean Med Sci 2005; 20: 9858.
  • 191
    Shin HR. Epidemiology of hepatitis C virus in Korea. Intervirology 2006; 49: 1822.
  • 192
    Kim YS, Ahn YO, Lee HS. Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype. J Korean Med Sci 2002; 17: 18792.
  • 193
    Shin HR, Kim JY, Kim JI, et al. Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture. Br J Cancer 2002; 87: 3148.
  • 194
    Suh DJ, Jeong SH. Current status of hepatitis C virus infection in Korea. Intervirology 2006; 49: 705.
  • 195
    Kwon JH, Bae SH. Current status and clinical course of hepatitis C virus in Korea. Korean J Gastroenterol 2008; 51: 3607.
  • 196
    Kim YS, Pai CH, Chi HS, et al. Prevalence of hepatitis C virus antibody among Korean adults. J Korean Med Sci 1992; 7: 3336.
  • 197
    Shin HR, Kim JY, Ohno T, et al. Prevalence and risk factors of hepatitis C virus infection among Koreans in rural area of Korea. Hepatol Res 2000; 17: 18596.
  • 198
    Park YM, Kim IS, Lee CD, Kim BS. Seroprevalence of antibody against hepatitis C virus (anti-HCV) in various groups of individuals in Korea. Gastroenterol Jpn 1991; 26 (Suppl. 3): 15963.
  • 199
    Baek EJ, Kim HO, Kim S, Park Q, Oh D. The trends for nationwide blood collection and the supply of blood in Korea during 2002–2006. Korean J Blood Transfus 2008; 19: 8390.
  • 200
    Lee H, Cho YK, Kim HU, et al. Distribution of hepatitis C virus genotypes in Jeju Island. Korean J Hepatol 2008; 14: 2835.
  • 201
    Park YS, Lee KO, Oh MJ, Chai YG. Distribution of genotypes in the 5′ untranslated region of hepatitis C virus in Korea. J Med Microbiol 1998; 47: 6437.
  • 202
    Han CJ, Lee HS, Kim HS, Choe JH, Kim CY. Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases. Korean J Intern Med 1997; 12: 217.
  • 203
    Lee DS, Sung YC, Whang YS. Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J Med Virol 1996; 49: 5560.
  • 204
    Kim CJ, Shin KS, Kim WY, et al. Genotype distribution and comparison of the putative envelope region of hepatitis C virus from Korean patients. J Med Virol 1995; 46: 3806.
  • 205
    Akhtar S, Rozi S. An autoregressive integrated moving average model for short-term prediction of hepatitis C virus seropositivity among male volunteer blood donors in Karachi, Pakistan. World J Gastroenterol 2009; 15: 160712.
  • 206
    Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009; 13: 919.
  • 207
    Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008; 41: 48.
  • 208
    Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008; 8: 69.
  • 209
    Idrees M, Lal A, Naseem M, Khalid M. High prevalence of hepatitis C virus infection in the largest province of Pakistan. J Dig Dis 2008; 9: 95103.
  • 210
    Aslam M, Aslam J, Mitchell BD, Munir KM. Association between smallpox vaccination and hepatitis C antibody positive serology in Pakistani volunteers. J Clin Gastroenterol 2005; 39: 2436.
  • 211
    Younus M, Siddiqi AE, Akhtar S. Reassessment of selected healthcare associated risk factors for HBV and HCV infections among volunteer blood donors, Karachi, Pakistan. Cent Eur J Public Health 2009; 17: 315.
  • 212
    Umar M, Busra MT, Ahmed M, et al. Hepatitis C in Pakistan: a review of available data. Hepatitis Monthly 2010; 10: 20514.
  • 213
    Jafri W, Subhan A. Hepatitis C in Pakistan: magnitude, genotype, disease characteristics and therapeutic response. Trop Gastroenterol 2008; 29: 194201.
  • 214
    Khattak MN, Akhtar S, Mahmud S, Roshan TM. Factors influencing Hepatitis C virus sero-prevalence among blood donors in north west Pakistan. J Public Health Policy 2008; 29: 20725.
  • 215
    Mujeeb SA, Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infect Dis 2008; 8: 43.
  • 216
    Abdul Mujeeb S, Nanan D, Sabir S, Altaf A, Kadir M. Hepatitis B and C infection in first-time blood donors in Karachi-a possible subgroup for sentinel surveillance. East Mediterr Health J 2006; 12: 73541.
  • 217
    Akhtar S, Younus M, Adil S, Jafri SH, Hassan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat 2004; 11: 52735.
  • 218
    Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc 2002; 52: 398402.
  • 219
    Abdul Mujeeb S, Aamir K, Mehmood K. Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc 2000; 50: 26970.
  • 220
    Kakepoto GN, Bhally HS, Khaliq G, et al. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health 1996; 27: 7036.
  • 221
    Sami S, Korejo R, Bhutta SZ. Prevalence of hepatitis B and C: a Jinnah Postgraduate Medical Centre experience. J Obstet Gynaecol Res 2009; 35: 5338.
  • 222
    Abbas Z, Jeswani NL, Kakepoto GN, et al. Prevalence and mode of spread of hepatitis B and C in rural Sindh, Pakistan. Trop Gastroenterol 2008; 29: 2106.
  • 223
    Butt T, Amin MS. Seroprevalence of hepatitis B and C infections among young adult males in Pakistan. East Mediterr Health J 2008; 14: 7917.
  • 224
    Khan S, Rai MA, Khan A, et al. Prevalence of HCV and HIV infections in 2005-Earthquake-affected areas of Pakistan. BMC Infect Dis 2008; 8: 147.
  • 225
    Ahmad N, Asgher M, Shafique M, Qureshi JA. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan. Saudi Med J 2007; 28: 3905.
  • 226
    Aziz S, Muzaffar R, Hafiz S, et al. Helicobacter pylori, hepatitis viruses A, C, E, antibodies and HBSAG-prevalence and associated risk factors in pediatric communities of Karachi. J Coll Physicians Surg Pak 2007; 17: 1958.
  • 227
    Mirza IA, Kazmi SMH, Janjua AN. Frequency of Hepatitis B surface antigen and anti-HCV in young adults-experience in southern Punjab. J Coll Physicians Surg Pak 2007; 17: 1145.
  • 228
    Alam M, Zaman Tariq W, Akram S, Zia Qureshi T. Frequency of hepatitis B and C in central Punjab. Pak J Pathol 2006; 17: 1401.
  • 229
    Jafri W, Jafri N, Yakoob J, et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006; 6: 101.
  • 230
    Mirza IA, Mirza SH, Irfan S, et al. Seroprevalence of Hepatitis B and C in young adults seeking recruitment in armed forces. Pak Armed Forces Med J 2006; 56: 1927.
  • 231
    Sherif TB, Tariq WZ. Seroprevalence of Hepatitis B and C in healthy adult male recruits. Pak J Pathol 2006; 17: 14750.
  • 232
    Muhammad N, Jan MA. Frequency of hepatitis “C” in Buner, NWFP. J Coll Physicians Surg Pak 2005; 15: 114.
  • 233
    Waseem R, Kashif MA, Khan M, Qureshi AW. Seroprevalence of HbsAg and anti-HCV in Ghurki Teaching Hospital, Lahore. Ann King Edward Med Coll 2005; 11: 2324.
  • 234
    Khokhar N, Gill ML, Malik GJ. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004; 14: 5346.
  • 235
    Rizvi TJ, Fatima H. Frequency of hepatitis C in obstetric cases. J Coll Physicians Surg Pak 2003; 13: 68890.
  • 236
    Shaikh MA, Shaikh WM, Solangi GA, Abro H. Frequency and transmission mode of hepatitis C virus in northern Sindh. J Coll Physicians Surg Pak 2003; 13: 6913.
  • 237
    Aziz S, Memon A, Tily HI, et al. Prevalence of HIV, hepatitis B and C amongst health workers of Civil Hospital Karachi. J Pak Med Assoc 2002; 52: 924.
  • 238
    Aslam M, Aslam J. Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan. J Clin Gastroenterol 2001; 33: 40711.
  • 239
    Khan AJ, Luby SP, Fikree F, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ 2000; 78: 95663.
  • 240
    Tanwani AK, Ahmad N. Prevalence of Hepatitis B surface antigen and Anti-Hepatitis C Virus in laboratory based data at Islamabad. J Surg 2000; 19–20: 259.
  • 241
    Tariq WU, Hussain AB, Karamat KA, et al. Demographic aspects of hepatitis C in northern Pakistan. J Pak Med Assoc 1999; 49: 198201.
  • 242
    Luby SP, Qamruddin K, Shah AA, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997; 119: 34956.
  • 243
    Agboatwalla M, Isomura S, Miyake K, et al. Hepatitis A, B and C seroprevalence in Pakistan. Indian J Pediatr 1994; 61: 5459.
  • 244
    Ally SH, Hanif R, Ahmed A. HBsAg and HCV: increasing test requests and decreasing frequency of positive tests at clinical laboratory of Ayub Teaching Hospital, Abbottabad. J Ayub Med Coll Abbottabad 2005; 17: 814.
  • 245
    Shah HA, Jafri W, Malik I, Prescott L, Simmonds P. Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol 1997; 12: 75861.
  • 246
    Al-Faleh FZ, Ramia S, Arif M, et al. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan area of Saudi Arabia: a community-based study. Ann Trop Med Parasitol 1995; 89: 4317.
  • 247
    Arif M, al-Swayeh M, Al-Faleh FZ, Ramia S. Risk of hepatitis C virus infection among household contacts of Saudi patients with chronic liver disease. J Viral Hepat 1996; 3: 97101.
  • 248
    Ahmad MS, Mahtab AM, Abdullatif AS, et al. Prevalence of antibodies against the hepatitis C virus among voluntary blood donors at a makkah hospital. Saudi J Kidney Dis Transpl 1995; 6: 1224.
  • 249
    Altraif I. Hepatitis C acquisition in Saudi Arabia: are the majority of cases without risk factor? Ann Saudi Med 1995; 15: 42830.
  • 250
    Fakeeh M, Zaki AM. Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia. Am J Trop Med Hyg 1999; 61: 88992.
  • 251
    Mahaba H, el-Tayeb A, Elbaz H. The prevalence of antibodies to hepatitis C virus in Hail region, Saudi Arabia. J Egypt Public Health Assoc 1999; 74: 6980.
  • 252
    al Nasser MN. Intrafamilial transmission of hepatitis C virus (HCV): a major mode of spread in the Saudi Arabia population. Ann Trop Paediatr 1992; 12: 2115.
  • 253
    Ayoola EA, al-Mofleh IA, Al-Faleh FZ, et al. Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases. Hepatogastroenterology 1992; 39: 3379.
  • 254
    Bahakim H, Bakir TM, Arif M, Ramia S. Hepatitis C virus antibodies in high-risk Saudi groups. Vox Sang 1991; 60: 1624.
  • 255
    Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998–2001. Clin Lab Haematol 2004; 26: 2258.
  • 256
    El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 2004; 25: 2633.
  • 257
    Qadi AA, Tamim H, Ameen G, et al. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control 2004; 32: 4935.
  • 258
    Tamimi WG, Altraif IM, Auumah A, et al. Impact of new AABB guidelines on hepatitis B and C testing among Saudi blood donors. Br J Biomed Sci 2004; 61: 2157.
  • 259
    Shobokshi OA, Serebour FE, Al-Drees AZ, et al. Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J 2003; 24: S816.
  • 260
    Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia. Transfusion 1994; 34: 1357.
  • 261
    Al-Mofarreh M, Fakunle YM, El-Karamany WM, et al. Prevalence of antibodies to hepatitis C virus in blood donors in Riyadh. Ann Saudi Med 1991; 11: 5013.
  • 262
    Bernvil SS, Andrews VJ, Kariem AA. Hepatitis C antibody prevalence in Saudi Arabian blood donor population. Ann Saudi Med 1991; 11: 5637.
  • 263
    Alzahrani AJ. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay. J Med Virol 2008; 80: 6036.
  • 264
    Njoh J, Zimmo S. Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah, Saudi Arabia. East Afr Med J 1997; 74: 8991.
  • 265
    Saxena AK, Panhotra BR, Naguib M, et al. Prevalence of hepatitis C antibodies among hemodialysis patients in Al-hasa region of saudi arabia. Saudi J Kidney Dis Transpl 2001; 12: 5625.
  • 266
    Harakati MS, Abualkhair OA, Al-Knawy BA. Hepatitis C Virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma. Saudi Med J 2000; 21: 7558.
  • 267
    Soyannwo MA, Khan N, Kommajosyula S, et al. Hepatitis C antibodies in haemodialysis and pattern of end-stage renal failure in Gassim, Saudi Arabia. Afr J Med Med Sci 1996; 25: 1322.
  • 268
    Huraib S, al-Rashed R, Aldrees A, et al. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995; 10: 4704.
  • 269
    al Karawi MA, Shariq S, el Shiekh Mohamed AR, Saeed AA, Ahmed AM. Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia. J Gastroenterol Hepatol 1992; 7: 2379.
  • 270
    Jamjoom GA, Quli SK. Serodiagnosis of hepatitis C in acute and chronic liver disease in southwestern Saudi Arabia. J Trop Med Hyg 1992; 95: 42831.
  • 271
    Mitwalli A, al-Mohaya S, al Wakeel J, et al. Hepatitis C in chronic renal failure patients. Am J Nephrol 1992; 12: 28891.
  • 272
    Ayoola EA, Huraib S, Arif M, et al. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. J Med Virol 1991; 35: 1559.
  • 273
    Al-Faleh FZ, Ayoola EA, al-Jeffry M, et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology 1991; 14: 2158.
  • 274
    Al-Tawfiq JA, Anani A. Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital. Med Sci Monit 2008; 14: CR526.
  • 275
    Madani TA. Hepatitis C virus infections reported over 11 years of surveillance in Saudi Arabia. Trans R Soc Trop Med Hyg 2009; 103: 1326.
  • 276
    Memish ZA, Knawy BA, El-Saed A. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis 2010; 14: e11520.
  • 277
    Al-Traif I, Handoo FA, Al-Jumah A, al Nasser MN. Chronic hepatitis C. Genotypes and response to anti-viral therapy among Saudi patients. Saudi Med J 2004; 25: 19358.
  • 278
    Shobokshi OA, Serebour FE, Skakni LI. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia. Saudi Med J 2003; 24: S8791.
  • 279
    Osoba AO, Ibrahim M, Abdelaal MA, et al. Hepatitis C virus genotyping by polymerase chain reaction and DNA enzyme immunoassay among Saudi patients in the Western Province, Saudi Arabia. Ann Saudi Med 2000; 20: 3947.
  • 280
    Al-Ahdal MN, Rezeig MA, Kessie G. Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from PCR-amplified core region of the virus genome. Ann Saudi Med 1997; 17: 6014.
  • 281
    Al-Knawy B, Okamoto H, Ahmed El-Mekki A, et al. Distribution of hepatitis C genotype and co-infection rate with hepatitis G in Saudi Arabia. Hepatol Res 2002; 24: 95.
  • 282
    Bosmans JL, Nouwen EJ, Behets G, et al. Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi-Arabia. Clin Nephrol 1997; 47: 25662.
  • 283
    Shobokshi OA, Serebour FE, Skakni L, Al-Saffy YH, Ahdal MN. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 1999; 58: 448.
  • 284
    Al-Faleh FZ, Huraib S, Sbeih F, et al. Hepatitis C virus genotypes in patients with chronic liver disease and haemodialysis patients from Saudi Arabia. J Viral Hepat 1995; 2: 2936.
  • 285
    Antaki N, Haddad M, Kebbewar K, et al. The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province. Epidemiol Infect 2009; 137: 7984.
  • 286
    Othman BM, Monem FS. Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria. Saudi Med J 2002; 23: 3935.
  • 287
    Othman B, Monem F. Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection 2001; 29: 2625.
  • 288
    Othman BM, Monem FS. Prevalence of hepatitis C virus antibodies among health care workers in Damascus, Syria. Saudi Med J 2001; 22: 6035.
  • 289
    Abdulkarim AS, Zein NN, Germer JJ, et al. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg 1998; 59: 5716.
  • 290
    Tsai MC, Kee KM, Chen YD, et al. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. J Gastroenterol Hepatol 2007; 22: 928.
  • 291
    Chen CH, Yang PM, Huang GT, et al. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007; 106: 14855.
  • 292
    Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999; 59: 2906.
  • 293
    Wang CS, Chang TT, Yao WJ, Chou P. Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. Am J Trop Med Hyg 2002; 66: 38993.
  • 294
    Lee PL, Wang JH, Tung HD, Lee CM, Lu SN. A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan. Trans R Soc Trop Med Hyg 2004; 98: 36772.
  • 295
    Dai CY, Huang JF, Hsieh MY, et al. The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C. Gut 2007; 56: 7378.
  • 296
    Sun CA, Chen HC, Lu SN, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 2001; 65: 304.
  • 297
    Huang JF, Lu SN, Chue PY, et al. Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies. Epidemiol Infect 2001; 127: 48592.
  • 298
    Lu SN, Chen HC, Tang CM, et al. Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J 1998; 17: 1425.
  • 299
    Lai MY. Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan. Intervirology 2006; 49: 915.
  • 300
    Chen DS, Kuo GC, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162: 81722.
  • 301
    Lee CM, Lu SN, Hung CH, et al. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications. Trans R Soc Trop Med Hyg 2006; 100: 76774.
  • 302
    Yu ML, Chuang WL, Chen SC, et al. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 2001; 65: 5865.
  • 303
    Liou YW, Chou P, Chen YM. Genotypic analysis of HCV infection in kinmen. J Microbiol Immunol Infect 2000; 33: 14953.
  • 304
    Kao JH, Chen PJ, Lai MY, et al. Genotypes of hepatitis C virus in Taiwan and the progression of liver disease. J Clin Gastroenterol 1995; 21: 2337.
  • 305
    Sunanchaikarn S, Theamboonlers A, Chongsrisawat V, et al. Seroepidemiology and genotypes of hepatitis C virus in Thailand. Asian Pac J Allergy Immunol 2007; 25: 17582.
  • 306
    Chunlertrith K, Sukeepaisarnjaroen W, Mairiang P, et al. Clinico-epidemiology of hepatitis C viral infection in northeastern Thailand. Southeast Asian J Trop Med Public Health 2000; 31: 2736.
  • 307
    Thaikruea L, Thongsawat S, Maneekarn N, et al. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Transfusion 2004; 44: 143340.
  • 308
    Ratanasuwan W, Sonji A, Tiengrim S, Techasathit W, Suwanagool S. Serological survey of viral hepatitis A, B, and C at Thai Central Region and Bangkok: a population base study. Southeast Asian J Trop Med Public Health 2004; 35: 41620.
  • 309
    Ishida T, Takao S, Settheetham-Ishida W, Tiwawech D. Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand. J Clin Virol 2002; 24: 315.
  • 310
    Wiwanitkit V. A note in the high prevalence of anti-HCV seropositivity among hilltribers in Mae Jam District, Northern Thailand. Viral Immunol 2002; 15: 6456.
  • 311
    Jittiwutikarn J, Thongsawat S, Suriyanon V, et al. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg 2006; 74: 11116.
  • 312
    Hansurabhanon T, Jiraphongsa C, Tunsakun P, et al. Infection with hepatitis C virus among intravenous-drug users: prevalence, genotypes and risk-factor-associated behaviour patterns in Thailand. Ann Trop Med Parasitol 2002; 96: 61525.
  • 313
    Apichartpiyakul C, Apichartpiyakul N, Urwijitaroon Y, et al. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand. Jpn J Infect Dis 1999; 52: 1213.
  • 314
    Luksamijarulkul P, Plucktaweesak S. High hepatitis C seroprevalence in Thai intravenous drug abusers and qualitative risk analysis. Southeast Asian J Trop Med Public Health 1996; 27: 6548.
  • 315
    Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health 2004; 35: 14754.
  • 316
    Nantachit N, Robison V, Wongthanee A, et al. Temporal trends in the prevalence of HIV and other transfusion-transmissible infections among blood donors in northern Thailand, 1990 through 2001. Transfusion 2003; 43: 7305.
  • 317
    Wiwanitkit V. Anti HCV seroprevalence among the voluntary blood donors in Thailand. Hematology 2005; 10: 4313.
  • 318
    Theamboonlers A, Chinchai T, Bedi K, et al. Molecular characterization of Hepatitis C virus (HCV) core region in HCV-infected Thai blood donors. Acta Virol 2002; 46: 16973.
  • 319
    Kanistanon D, Neelamek M, Dharakul T, Songsivilai S. Genotypic distribution of hepatitis C virus in different regions of Thailand. J Clin Microbiol 1997; 35: 17726.
  • 320
    Doi H, Apichartpiyakul C, Ohba KI, Mizokami M, Hotta H. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 1996; 34: 56974.
  • 321
    Nakata S, Song P, Duc DD, et al. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Gastroenterol Hepatol 1994; 9: 4169.
  • 322
    Kakumu S, Sato K, Morishita T, et al. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam. J Med Virol 1998; 54: 2438.
  • 323
    Song P, Duc DD, Hien B, et al. Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi, Vietnam. Clin Diagn Lab Immunol 1994; 1: 4138.
  • 324
    Nakano T, Lu L, Liu P, Pybus OG. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 2004; 190: 1098108.
  • 325
    Nguyen VT, McLaws ML, Dore GJ. Prevalence and risk factors for hepatitis C infection in rural north Vietnam. Hepatol Int 2007; 1: 38793.
  • 326
    Tran HT, Ushijima H, Quang VX, et al. Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res 2003; 26: 27580.
  • 327
    Tokita H, Okamoto H, Tsuda F, et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 1994; 91: 110226.
  • 328
    Pham DA, Leuangwutiwong P, Jittmittraphap A, et al. High prevalence of Hepatitis C virus genotype 6 in Vietnam. Asian Pac J Allergy Immunol 2009; 27: 15360.
  • 329
    Jokhio AH, Bhatti TA, Memon S. Knowledge, attitudes and practices of barbers about hepatitis B and C transmission in Hyderabad, Pakistan. East Mediterr Health J 2010; 16: 107984.
  • 330
    Ruan Y, Jia Y, Zhang X, et al. Incidence of HIV-1, syphilis, hepatitis B, and hepatitis C virus infections and predictors associated with retention in a 12-month follow-up study among men who have sex with men in Beijing, China. J Acquir Immune Defic Syndr 2009; 52: 60410.
  • 331
    Hao C, Yan H, Yang H, et al. The incidence of syphilis, HIV and HCV and associated factors in a cohort of men who have sex with men in Nanjing, China. Sex Transm Infect 2011; 87: 199201.
  • 332
    Qazi HA, Saleem K, Mujtaba I, Hashmi A, Soomro JA. Prevalence and factors associated with HCV (hepatitis C virus) seropositivity in Islamabad, Pakistan. Acta Med Iran 2010; 48: 3948.